* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, September 13, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

    Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

    Behind the turntables: DJ Johnny Kage’s story of perseverance – yahoo.com

    Behind the Turntables: DJ Johnny Kage’s Inspiring Journey of Perseverance

    The other WWE star James Gunn wanted for Peacemaker instead of John Cena – yahoo.com

    The WWE Star James Gunn Originally Wanted for Peacemaker Instead of John Cena

    Quinta Brunson, John Stamos Join Entertainment and Technology Summit – Variety

    Quinta Brunson and John Stamos to Headline Thrilling Entertainment and Technology Summit

    ‘Breaking Bad’ star arrested for incident with neighbor. Here’s the latest – PennLive.com

    Breaking Bad’ Star Arrested Following Neighbor Dispute: Latest Updates

    Palmetto Sports & Entertainment to air Columbia Fireflies playoff games – WIS News 10

    Catch Every Thrilling Moment: Palmetto Sports & Entertainment to Broadcast Columbia Fireflies Playoff Games!

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

    Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

    Aston Martin to integrate Pirelli’s cyber tyre technology in future models – Just Auto

    Aston Martin to Revolutionize Future Models with Pirelli’s Cutting-Edge Cyber Tyre Technology

    Figure Technology’s stock sizzles after IPO, as investors stay hungry for crypto deals – MarketWatch

    Figure Technology’s Stock Skyrockets After IPO Amid Surging Crypto Investor Excitement

    AI is the ‘most transformational technology’ in our lifetime, AMD CEO argues – Fox Business

    AMD CEO Declares AI the Most Transformative Technology of Our Era

    PAR Technology (PAR) Unveils AI-Powered Assistant Enhancing Restaurant Operations and Customer Engagement – simplywall.st

    PAR Technology Unveils AI-Powered Assistant to Revolutionize Restaurant Operations and Boost Customer Engagement

    Lincoln Laboratory technologies win seven R&D 100 Awards for 2025 – MIT News

    Lincoln Laboratory Technologies Secure Seven Prestigious R&D 100 Awards for 2025

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

    Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

    Behind the turntables: DJ Johnny Kage’s story of perseverance – yahoo.com

    Behind the Turntables: DJ Johnny Kage’s Inspiring Journey of Perseverance

    The other WWE star James Gunn wanted for Peacemaker instead of John Cena – yahoo.com

    The WWE Star James Gunn Originally Wanted for Peacemaker Instead of John Cena

    Quinta Brunson, John Stamos Join Entertainment and Technology Summit – Variety

    Quinta Brunson and John Stamos to Headline Thrilling Entertainment and Technology Summit

    ‘Breaking Bad’ star arrested for incident with neighbor. Here’s the latest – PennLive.com

    Breaking Bad’ Star Arrested Following Neighbor Dispute: Latest Updates

    Palmetto Sports & Entertainment to air Columbia Fireflies playoff games – WIS News 10

    Catch Every Thrilling Moment: Palmetto Sports & Entertainment to Broadcast Columbia Fireflies Playoff Games!

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

    Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

    Aston Martin to integrate Pirelli’s cyber tyre technology in future models – Just Auto

    Aston Martin to Revolutionize Future Models with Pirelli’s Cutting-Edge Cyber Tyre Technology

    Figure Technology’s stock sizzles after IPO, as investors stay hungry for crypto deals – MarketWatch

    Figure Technology’s Stock Skyrockets After IPO Amid Surging Crypto Investor Excitement

    AI is the ‘most transformational technology’ in our lifetime, AMD CEO argues – Fox Business

    AMD CEO Declares AI the Most Transformative Technology of Our Era

    PAR Technology (PAR) Unveils AI-Powered Assistant Enhancing Restaurant Operations and Customer Engagement – simplywall.st

    PAR Technology Unveils AI-Powered Assistant to Revolutionize Restaurant Operations and Boost Customer Engagement

    Lincoln Laboratory technologies win seven R&D 100 Awards for 2025 – MIT News

    Lincoln Laboratory Technologies Secure Seven Prestigious R&D 100 Awards for 2025

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Esketamine Tops Quetiapine in Treatment-Resistant Depression

October 5, 2023
in Health
Esketamine Tops Quetiapine in Treatment-Resistant Depression
Share on FacebookShare on Twitter

Esketamine nasal spray (Spravato) led to better remission rates compared with extended-release quetiapine (Seroquel XR) in patients with treatment-resistant depression when used in combination with ongoing treatment, the randomized phase IIIb ESCAPE-TRD trial showed.

Among patients who were taking a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI), those who received adjunctive intranasal esketamine had better rates of remission at 8 weeks compared with adjunctive quetiapine (27.1% vs 17.6%; adjusted OR 1.74, 95% CI 1.20-2.52) based on the Montgomery-Åsberg Depression Rating Scale (MADRS), reported Andreas Reif, MD, of the University Hospital Frankfurt-Goethe University in Germany, and co-authors.

In addition, 21.7% of patients in the esketamine group had no relapse through 32 weeks after remission at week 8 versus 14.1% of those in the quetiapine group (aOR 1.72, 95% CI 1.15-2.57), they noted in the New England Journal of Medicine.

“Approximately one-third of people who suffer from major depressive disorder do not respond to treatment and are considered to have treatment-resistant depression,” Reif told MedPage Today in an email. “Research into treatments for treatment-resistant depression is essential, to help break the cycle of treatment failure and to combat the devastating impact that treatment-resistant depression has on people living with the condition.”

“Remission is the ultimate goal for the acute phase of antidepressive treatment, followed by preventing relapse once remission is achieved,” he noted. “The primary and key secondary endpoints represent major milestones in the course of treating depression for patients and clinicians and are even more significant and difficult to achieve in a treatment-resistant depression participant population.”

He noted that the rates of remission and relapse were in line with expectations based on previous studies, but that the continued increase in these rates all the way up to week 32 was unexpected. “This consolidates the importance of esketamine nasal spray as a long-term therapeutic option for adults with treatment-resistant depression,” he said.

“Given the different methods of administration of the two medicines … conducting the study open-label avoided the need to use a placebo, which reduced the burden on study patients in the quetiapine extended-release arm in terms of less frequent visits to treatment [centers],” he added.

In an accompanying editorial, Rupert McShane, MD, of the Oxford Health NHS Foundation Trust and the University of Oxford in England, noted that the trial provided positive progress in research on the use of esketamine nasal spray.

“Real-world experience with esketamine nasal spray has also been reassuring,” he wrote. “Cystitis and cognitive impairment remain theoretical, rather than actual, risks. Similarly, overuse is prevented because the nasal spray has to be administered in the clinic, which also enhances the opportunity for regular review.”

Despite the concerns around the use of esketamine in clinical settings, McShane said that this trial “supports the radical and disruptive idea that esketamine nasal spray has a place early in the sequence of antidepressant treatment.”

For this study, patients were recruited from August 2020 through November 2021 at 171 sites — including hospitals, inpatient and outpatient clinics, and research centers — across 24 countries.

Reif and colleagues randomized 336 patients to receive a flexible dose of esketamine nasal spray (median age 45, 67% women) and 340 patients to extended-release quetiapine (median age 47, 65.3% women) in combination with an SSRI or SNRI. The primary endpoint was remission at 8 weeks defined by a score of 10 or less on the MADRS (scores range from 0 to 60, with higher scores indicating more severe depression).

All enrolled patients were included in the analysis, with patients who discontinued treatment being counted as having an unfavorable outcome.

As for other secondary endpoints, patients in the esketamine group were more likely to be in remission at 32 weeks compared with those in the quetiapine group (49.1% vs 32.9%; OR 1.96, 95% CI 1.44-2.68). Similarly, 65.5% of patients in the esketamine group showed a treatment response at 32 weeks compared with 47.1% of those in the quetiapine group (OR 2.13, 95% CI 1.57-2.91).

Adverse events occurred in most patients in both the esketamine group (91.9%) and the quetiapine group (78%), but serious adverse events were far less common (5.7% vs 5.1%, respectively). The researchers noted that two patients in the esketamine group had serious adverse events — acute coronary syndrome at 21 weeks and dizziness at 2 weeks — that were considered to be related to the treatment. There were no serious adverse events considered to be related to treatment in the quetiapine group.

author['full_name']

Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news. Follow

Disclosures

This study was funded by Janssen EMEA.

Reif reported consulting for Boehringer Ingelheim GmbH, Compass, Janssen Pharmaceuticals, LivaNova USA, Medice, Sage Therapeutics, and Shire.

Co-authors reported multiple relationships with industry.

McShane reported a relationship with Janssen Pharmaceuticals.

Primary Source

New England Journal of Medicine

Source Reference: Reif A, et al “Esketamine nasal spray versus quetiapine for treatment-resistant depression” N Engl J Med 2023; DOI: 10.1056/NEJMoa2304145.

Secondary Source

New England Journal of Medicine

Source Reference: McShane R “Loosening the shackles of depression” N Engl J Med 2023; DOI: 10.1056/NEJMe2309758.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/psychiatry/depression/106642

Tags: EsketaminehealthQuetiapine
Previous Post

San Francisco-based OWN Real Estate makes the leap to Keller Williams

Next Post

How Bad Will This Respiratory Virus Season Be? CDC Weighs In.

UW-Stevens Point hosts lecture on cannabis culture and research – Stevens Point Journal

UW-Stevens Point hosts lecture on cannabis culture and research – Stevens Point Journal

September 13, 2025
Southern Miss to Host 7th Annual Rayborn Lecture Featuring Renowned Physical Chemist – The University of Southern Mississippi

Southern Miss Welcomes Renowned Physical Chemist for 7th Annual Rayborn Lecture

September 13, 2025
Shreveport couple accused of defrauding Medicaid to fund cosmetic surgery, luxury lifestyle – WAFB

Shreveport Couple Accused of Using Medicaid Fraud to Fund Cosmetic Surgery and Extravagant Lifestyle

September 13, 2025
Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

September 13, 2025
Fall sports programs relish — or ignore — early effects of new roster limits – The Cavalier Daily

Fall Sports Programs Embrace or Overlook Early Impact of New Roster Limits

September 13, 2025
Australia approves world-first vaccine to save koalas from chlamydia – AP News

Australia Approves Groundbreaking Vaccine to Protect Koalas from Chlamydia

September 12, 2025
I got a discounted premium economy seat by bidding. It made my 10-hour flight better, but I wouldn’t pay full price for it. – Business Insider

How Bidding for a Discounted Premium Economy Seat Transformed My 10-Hour Flight-But It’s Not Worth Paying Full Price

September 12, 2025
Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

September 12, 2025
New global collaboration uses UC Davis experts and AI to spot the next pandemic – University of California – Davis Health

Global Collaboration Harnesses UC Davis Experts and AI to Detect the Next Pandemic Early

September 12, 2025
Why pesticides could threaten a MAGA-MAHA political divorce – CNN

Why pesticides could threaten a MAGA-MAHA political divorce – CNN

September 12, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (818)
  • Economy (837)
  • Entertainment (21,715)
  • General (17,006)
  • Health (9,880)
  • Lifestyle (852)
  • News (22,149)
  • People (841)
  • Politics (845)
  • Science (16,047)
  • Sports (21,337)
  • Technology (15,819)
  • World (819)

Recent News

UW-Stevens Point hosts lecture on cannabis culture and research – Stevens Point Journal

UW-Stevens Point hosts lecture on cannabis culture and research – Stevens Point Journal

September 13, 2025
Southern Miss to Host 7th Annual Rayborn Lecture Featuring Renowned Physical Chemist – The University of Southern Mississippi

Southern Miss Welcomes Renowned Physical Chemist for 7th Annual Rayborn Lecture

September 13, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version